Announcement made today:
Allied Healthcare Group announced the successful results of a joint study with CSIRO which found the company's CardioCel tissue patches offers superiority for stem cells survival and growth compared to the gold-standard tissues now in surgical use. The study compared the performance of CardioCel engineered tissue against glutaraldehyde-prepared tissue (the control) which is widely used in cardiac repair surgery, and assessed their ability to maintain a viable population of mesenchymal stems cells (MSCs). These results support the continuation of the development of CardioCel and other ADAPT treated tissue based products as new platforms for the proliferation and delivery of stem cells.
(Source: Morningstar/Netwealth)
Announcement made today:Allied Healthcare Group announced the...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.059B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 92.0¢ | $1.393M | 1.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 15601 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 83.0¢ | 10900 | 1 |
View Market Depth
| Last trade - 15.59pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |